StockData
Veradermics, Inc logo

Veradermics, Inc (MANE) stock

MANENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$125.64−2.41 (-1.88%)

Close on Nov 17, 2026Market cap $5.25BP/E –Yield –

Veradermics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Veradermics

Veradermics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Veradermics figures

See a number that looks wrong?